Skip to main content

MCC - Adjuvant Radiation Therapy: Evidence and Outcomes

Dermatologic Surgery

JC: November 2023

This study evaluated the evidence for adjuvant radiation therapy in Merkel cell carcinoma, analyzing its impact on local recurrence, regional control, and overall survival. The review synthesized data from multiple studies to assess when adjuvant radiation provides benefit beyond surgery alone, considering factors such as tumor size, margin status, and nodal involvement.

Take-Home Messages

  • Adjuvant radiation reduces local and regional recurrence in MCC, particularly for tumors with positive or close margins.
  • The benefit of adjuvant radiation is most pronounced for primary tumors >2 cm and those with nodal involvement.
  • Radiation field and dose protocols for MCC remain variable across institutions, highlighting the need for standardized guidelines.

Topic

SCC Systemic Therapy

Adjuvant immunotherapy, cemiplimab, radiation for high-risk cSCC

Related MohsPedia Articles

Literature review only. This summary is an editorial interpretation and may not reflect the complete findings of the original publication. Always refer to the full-text article for clinical decision-making.